January 28, 2018 .
Healthcare Market Reports has been published today new report. It provides updated in 2018 year analysis of Healthcare Industries.
The RNAi Therapeutics Market, 2015 – 2030 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Genomics, Healthcare Markets.
Discovered less than two decades ago, RNAi has made its presence felt in all spheres of the pharmaceutical industry. RNAi is a natural post-transcriptional process of gene silencing involving short strands of nucleic acids. It is a regulatory process that cells utilise to silence and/or inhibit gene expression through the destruction of specific mRNA molecules.
One of the major advantages of RNAi is that it enables sequence specific knockdown of a target gene. Indications, such as age-related macular degeneration (AMD), hepatitis C and various forms of cancer,which are hard to address with the available therapies, are being considered as potential areas that can benefit from RNAi based therapeutics.
...